Efficacy and Safety of Fixed-dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Black Participants with Moderate to Severe Acne.
Saved in:
| Title: | Efficacy and Safety of Fixed-dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Black Participants with Moderate to Severe Acne. |
|---|---|
| Authors: | Callender VD; Dr. Callender is with Callender Dermatology and Cosmetic Center in Glenn Dale, Maryland, and the Howard University College of Medicine in Washington, District of Columbia., Alexis AF; Dr. Alexis is with Weill Cornell Medicine in New York, New York. Dr., Bhatia N; Bhatia is with Therapeutics Clinical Research in San Diego, California., Harper JC; Dr. Harper is with the Dermatology & Skin Care Center of Birmingham in Birmingham, Alabama., Baldwin H; Dr. Baldwin is with The Acne Treatment and Research Center in Brooklyn, New York, and Robert Wood Johnson University Hospital in New Brunswick, New Jersey., Guenin E; Dr. Guenin is with Ortho Dermatologics, a division of Bausch Health US, LLC, in Bridgewater, New Jersey., Kircik LH; Dr. Kircik is with the Icahn School of Medicine at Mount Sinai in New York, New York; Indiana University School of Medicine in Indianapolis, Indiana; Physicians Skin Care, PLLC, DermResearch, PLLC, and Skin Sciences, PLLC in Louisville, Kentucky. |
| Source: | The Journal of clinical and aesthetic dermatology [J Clin Aesthet Dermatol] 2025 Apr; Vol. 18 (4), pp. 10-16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Matrix Medical Communications Country of Publication: United States NLM ID: 101518173 Publication Model: Print Cited Medium: Print ISSN: 1941-2789 (Print) Linking ISSN: 19412789 NLM ISO Abbreviation: J Clin Aesthet Dermatol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
